This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Dr. Martens Management
Management criteria checks 3/4
Dr. Martens' CEO is Kenny Wilson, appointed in Jul 2018, has a tenure of 4.92 years. total yearly compensation is £773.00K, comprised of 93.3% salary and 6.7% bonuses, including company stock and options. directly owns 1.12% of the company’s shares, worth MX$312.89M. The average tenure of the management team and the board of directors is 3.5 years and 2.4 years respectively.
Key information
Kenny Wilson
Chief executive officer
UK£773.0k
Total compensation
CEO salary percentage
93.27%
CEO tenure
4.9yrs
CEO ownership
1.1%
Management average tenure
3.5yrs
Board average tenure
2.4yrs
Recent management updates
Recent updates
CEO Compensation Analysis
How has Kenny Wilson's remuneration changed compared to Dr. Martens's earnings?
Date
Total Compensation
Salary
Company Earnings
Mar 31 2023
UK£773k
UK£721k
UK£129m
Dec 31 2022
n/a
n/a
UK£153m
Sep 30 2022
n/a
n/a
UK£177m
Jun 30 2022
n/a
n/a
UK£179m
Mar 31 2022
UK£2m
UK£700k
UK£181m
Dec 31 2021
n/a
n/a
UK£118m
Sep 30 2021
n/a
n/a
UK£54m
Jun 30 2021
n/a
n/a
UK£44m
Mar 31 2021
UK£815k
UK£118k
UK£35m
Compensation vs Market: Kenny's total compensation ($USD977.03K) is about average for companies of similar size in the MX market ($USD872.09K).
Compensation vs Earnings: Kenny's compensation has been consistent with company performance over the past year.
CEO
Kenny Wilson (56 yo)
4.9yrs
Tenure
UK£773,000
Compensation
Mr. Kenneth Wilson, also known as Kenny, is Chief Executive Officer at Dr. Martens Limited and Dr. Martens plc since July 2018 and serves as its Director since January 5, 2021. He joined Dr. Martens Limite...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Kenneth Wilson
CEO & Director
4.9yrs
UK£773.00k
1.12% MX$ 312.9m
Jon Mortimore
CFO & Director
7.2yrs
UK£503.00k
0.64% MX$ 177.8m
Geert Peeters
Chief Operating Officer
5yrs
no data
no data
Ronald Garricks
Chief Information Officer
3.2yrs
no data
no data
Emily Reichwald
General Counsel & Company Secretary
8.2yrs
no data
no data
Meg Johnson
Chief Marketing Officer
1.2yrs
no data
no data
Sue Gannon
Chief Human Resources Officer
2yrs
no data
no data
Lorenzo Moretti
President of EMEA
3.2yrs
no data
no data
Sean O'Neill
Chief Digital Officer
5.2yrs
no data
no data
Derek Chan
President of APAC
3.8yrs
no data
no data
Adam Meek
Chief Product Officer
1.5yrs
no data
no data
Jennifer Somer
President of Americas
1.6yrs
no data
no data
3.5yrs
Average Tenure
Experienced Management: DOCS N's management team is considered experienced (3.5 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
Kenneth Wilson
CEO & Director
2.4yrs
UK£773.00k
1.12% MX$ 312.9m
Jon Mortimore
CFO & Director
2.4yrs
UK£503.00k
0.64% MX$ 177.8m
Andrew Harrison
Independent Non-Executive Director
less than a year
no data
no data
Ian Rogers
Independent Non-Executive Director
2.4yrs
UK£67.00k
0.0020% MX$ 566.5k
Robyn Perriss
Independent Non-Executive Director
2.4yrs
UK£94.00k
0.0099% MX$ 2.8m
Tara Alhadeff
Representative Non-Executive Director
8.1yrs
no data
no data
Lynne Weedall
Senior Independent Non-Executive Director
2.4yrs
UK£99.00k
0.0021% MX$ 586.0k
Ije Nwokorie
Independent Non-Executive Director
2.4yrs
UK£67.00k
0.00054% MX$ 150.7k
Paul Mason
Chair of the Board
7.8yrs
UK£335.00k
0.79% MX$ 219.6m
2.4yrs
Average Tenure
54yo
Average Age
Experienced Board: DOCS N's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2023/06/14 10:55
End of Day Share Price
2023/03/17 00:00
Earnings
2023/03/31
Annual Earnings
2023/03/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Dr. Martens plc is covered by 13 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.